We have broad expertise in integrin drug discovery with an extensive publication track record.

  • Delivered small molecule integrin inhibitors of clinical quality
  • Experience of selecting different routes of administration for integrin inhibitors (oral, iv, inhaled, long acting parenteral)
  • Knowledge of selecting the most appropriate integrin tools, probes and standards for biological studies and screening assays
  • Application to the treatment of multiple diseases such as fibrosis and cancer
  • Up-to-date competitor knowledge and patents
Scroll to Top